Consumer Defensive
Jyothy Labs Limited Q2 FY27: Revenue Up 12.4%, Profitability Hit by Input Costs
Jyothy Labs Limited (NSE: JYOTHYLAB) reports Q2 FY27 results with revenue up 12.4%, but profitability impacted by high input costs.
Jyothy Labs Limited (NSE: JYOTHYLAB) announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company’s underlying business continued to demonstrate healthy growth, supported by strong performance in Fabric Care, sustained momentum in the Exo franchise, new product launches, and improving contributions from emerging trade channels.
Financial Highlights
Financial highlights for Q2 FY27 (YoY) include: revenue from operations at ₹760 crore, representing 3.3% reported value growth. Excluding Pril and Fa, revenue grew by 12.4% in value and 8.1% in volume. Operating EBITDA stood at ₹19.2 crore with an EBITDA margin of 2.5%. Profit After Tax was ₹10.6 crore.
Segment Performance
The Fabric Care segment delivered 10.4% value growth and 6.4% volume growth during the quarter. The Home Care segment delivered healthy underlying growth of 15.3% in value and 13.1% in volume, excluding Pril sales. Personal Care recorded 11.2% value growth during the quarter.
Management Outlook
Ms. M. R. Jyothy, Chairperson and Managing Director, Jyothy Labs Limited, stated that despite the company’s strong underlying growth, unprecedented inflation in raw material and packaging costs significantly impacted profitability. The company remains focused on progressively restoring margins through calibrated pricing, operational efficiencies, and disciplined cost management.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Jyothy Labs Limited
Jyothy Labs Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Jyothy trades in the lower quarter of its 52-week range. Thin margins at 9.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The PEG of 2.12 is on the high side. However, it is acceptable for a quality compounder with a strong moat. The stock sits at 7% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 5.8% and profits at 11.6% CAGR — a genuinely strong business. Nevertheless, the stock drops 5.1% in three months. The market sells the stock, not the story. Watch whether that changes at the next earnings. Check Fundamentals of Jyothy Labs Limited.
CLEDUCATE
Cl Educate Limited (cleducate) Analyst Presentation H1 FY 2027: Strategic Transformation Drives Cost Discipline
CL Educate Limited (CLEDUCATE) reports strategic transformation and cost discipline in H1 FY 2027, boosting EBITDA by 13.2%.
CL Educate Limited (CLEDUCATE) showcased significant strategic transformation and cost discipline in its H1 FY 2027 results, driving a 13.2% increase in EBITDA. Despite a 4.4% decline in total income, the company managed to lift its EBITDA margin by 289 bps to 18.6%. This was primarily driven by ₹ 20.5 Cr in cost reduction, which more than offset the ₹ 13.9 Cr decline in total income. The company’s focus on cost optimization was evident across all segments, with notable improvements in the EdTech – Learning & Development and Digital Assessments segments.
Cost Optimization Lifts EBITDA
The company’s cost reduction initiatives, particularly in service delivery and other overheads, played a crucial role in this performance. The finance cost decreased by 32.0% to ₹ 17.8 Cr, while depreciation and amortization increased by 21.4% to ₹ 22.5 Cr. Despite these changes, the overall EBITDA rose to ₹ 56.8 Cr from ₹ 50.2 Cr in H1 FY 2026, highlighting the effectiveness of the company’s cost management strategies.
Segment Performance
In terms of segment performance, the EdTech – Learning & Development segment saw a 12% increase in EBITDA, with the margin expanding by 426 bps to 21.8%. The Digital Assessments segment also contributed significantly, with a 26.7% rise in EBITDA and a 171 bps increase in the EBITDA margin. These results underscore the company’s strategic focus on enhancing operational efficiency and driving growth across its key business lines.
Looking ahead, CL Educate Limited remains committed to its strategic transformation initiatives, aiming to leverage its integrated solutioning platform to deliver sustained value to its stakeholders. The company’s forward-looking approach positions it well to navigate the evolving market landscape and capitalize on new opportunities.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of CL Educate Limited
CL Educate Limited belongs to the Consumer Defensive › Education & Training Services sector. Here’s a quick read on where the business and the stock stand today.
CL moves sideways over three months, with neither buyers nor sellers taking control. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock gains 0.7% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 23.7% yet the PEG reaches 99.00 — expensive for that growth. Furthermore, the stock drops 1.4% in three months. Neither value nor momentum supports this setup. It needs an earnings beat or a price reset first. Check Fundamentals of CL Educate Limited.
ABDL
Allied Blenders and Distillers Limited (abdl) Records Highest Ever Monthly Sales in Festive Season
Allied Blenders and Distillers Limited (ABDL) reports highest-ever monthly sales in October 2026, exceeding 3.6 million cases.
Allied Blenders and Distillers Limited (ABDL) announced its highest-ever monthly sales in October 2026, exceeding 3.6 million cases. This milestone follows a record-breaking September with over 3.5 million cases sold, marking two consecutive months of unprecedented sales volumes. Officer’s Choice Brandy and Sumo Whisky achieved millionaire brand status, bringing ABDL’s tally to six millionaire brands.
Sustained Market Demand
The growth reflects consistent demand across ABDL’s portfolio, with festive season-led demand providing additional momentum. This performance is underpinned by enduring strength of the company’s core brands, highlighted by Officer’s Choice Brandy joining the millionaire brands club. Driven by strong consumer response, the brand has achieved near double-digit market share in the key southern states within the Mass Premium category.
Broad-Based Growth
The growth was broad-based, with contributions from across regions and the defence market. Additionally, international markets played an important role in maintaining this momentum. With this milestone, ABDL now boasts six millionaire brands in its portfolio, further reinforcing its market presence and product depth across key categories.
ABDL continues to expand its premiumisation journey, with its flagship Officer’s Choice, Sterling Reserve, and the rapidly scaling ICONiQ White. As part of its premiumisation journey, ABDL has expanded into the super-premium and luxury segments through its subsidiary – ABD Maestro Pvt Ltd.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Allied Blenders and Distillers Limited
Allied Blenders and Distillers Limited belongs to the Consumer Defensive › Beverages – Wineries & Distilleries sector. Here’s a quick read on where the business and the stock stand today.
Allied gains 21.4% over three months and trades near its 52-week highs. The PEG of 0.23 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Thin margins at 5.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Buyers show up with 2.0x the volume of sellers. Moreover, they dominated on 19 of recent sessions versus 11 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 7.4%, profits at 422.6%, and the PEG sits at 0.23 — below its growth rate. That combination is rare. Check Fundamentals of Allied Blenders and Distillers Limited.
Consumer Defensive
Parag Milk Foods Limited Q2 & H1 FY27: Highest Ever Quarterly Revenue Rs. 1,241 Cr
Parag Milk Foods Limited (PARAGMILK) reports Q2 FY27 revenue of Rs. 1,241 Cr, a 23% YoY increase, driven by strong volume growth.
Parag Milk Foods Limited (PMFL) announced its un-audited financial results for the quarter and half year ended September 30, 2026, marking a significant milestone with the highest-ever quarterly revenue of Rs. 1,241 crore, a robust 23% year-on-year growth. This impressive performance was backed by a 12% volume growth and a 37% year-on-year increase in EBITDA.
Quarterly Highlights
The consolidated financial performance for Q2 FY27 showcased a revenue of Rs. 1,241 crore, with a gross profit of Rs. 323 crore, up 24% YoY. The EBITDA surged by 37% to Rs. 101 crore, contributing to an EBITDA margin of 8.1%. Despite an 8% decline in PAT, the profit after tax grew by 42% excluding last year’s one-off gain of Rs. 16 crore.
Half-Year Performance
For H1 FY27, the revenue stood at Rs. 2,185 crore, reflecting an 8% volume growth and an 18% value growth. The EBITDA increased by 23% to Rs. 170 crore, with an EBITDA margin of 7.8%. The PAT, although showing a 13% decline, grew by 12% excluding the one-off gain from the previous year.
Strategic Investments and Expansion
PMFL is also investing heavily in capacity expansion. The board approved a plan to scale paneer capacity from 20 MT/day to 80 MT/day by June 2027, with an investment of approximately Rs. 100 crore. Additionally, cheese capacity is being doubled from 60 MT/day to 120 MT/day at an investment of Rs. 105 crore, expected to be completed by FY28. These initiatives aim to strengthen the company’s scale and support its shift towards value-added, protein-led offerings.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Parag Milk Foods Limited
Parag Milk Foods Limited belongs to the Consumer Defensive › Packaged Foods sector. Here’s a quick read on where the business and the stock stand today.
Parag rises 23.5% over three months, with buying pressure holding steady. The PEG of 0.77 signals undervaluation relative to growth. It is a potential re-rating candidate. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Buyers show up with 1.6x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. The stock rises 23.5% in three months on 9.6% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Parag Milk Foods Limited.
-
Industrials3 days agoZen Technologies Limited (zentec) Q2 & H1fy27: Record Revenue and Order Book Growth
-
Advertising Agencies3 days agoAffle 3i Limited Announces Acquisition of Perion to Scale CPCU Business
-
Drug Manufacturers - General3 days agoSai Parenterals Limited Q2 & H1 FY27: Revenue Up 9%, PAT Grows 32.7%
-
AKUMS2 days agoAkums Drugs and Pharmaceuticals Limited (akums) Q2 FY27: Revenue Up 32%, Ebitda and PAT Surge
-
COALINDIA3 days agoCoal India Limited (coalindia) Records All-time High Coal Supplies in October FY’27
-
Information Technology Services2 days agoOrient Technologies Limited (orienttech) Q2 FY27: Strong Profitability on Higher Managed Services Contribution
-
Consumer Cyclical2 days agoTbo Tek Limited (tbotek) Q2 FY27: Revenue Up 53%, Adj. Ebitda at ₹152 Crores
-
Auto Parts2 days agoJay Bharat Maruti Limited Q2 FY’27 Results: PAT Up 72.59%, Revenue Grows 41.97%
